BRCA1 and BRCA1 Genes and Inherited Breast And/or Ovarian Cancer: Benefits of Genetic Testing

Overview

Journal Indian J Surg Oncol

Specialty Oncology

Date 2012 Jun 14

PMID 22693372

Citations 2

Authors

Kumaravel Somasundaram

Affiliations

Soon will be listed here.

Abstract

The breast cancer associated genes BRCA1 and BRCA2 were discovered in 1994 and 1995 respectively. Since then in addition to our understanding how these proteins function in particular reference to DNA repair, enormous amount of knowledge has been gained regarding genetic epidemiology of inherited breast and ovarian cancer, mutation prevalence among different ethnic groups, presence of founder mutations, varying penetrance, genetic testing and potential management options of mutation carriers. This review will focus on the status of understanding of the role of BRCA1 and BRAC2 mutations among Indian women, structure and biology of these two genes, different methods used for mutation detection and different management options available for BRCA1 and BRCA2 mutation carriers.

Citing Articles

Breast cancer in the era of integrating "Omics" approaches.

Rossi C, Cicalini I, Cufaro M, Consalvo A, Upadhyaya P, Sala G Oncogenesis. 2022; 11(1):17.

PMID: 35422484 PMC: 9010455. DOI: 10.1038/s41389-022-00393-8.

Feasibility of genetic testing for cancer risk assessment programme in Nigeria.

Adejumo P, Aniagwu T, Awolude O, Oni A, Ajayi O, Fagbenle O Ecancermedicalscience. 2021; 15:1283.

PMID: 34824606 PMC: 8580592. DOI: 10.3332/ecancer.2021.1283.

References

Gerhardus A, Schleberger H, Schlegelberger B, Gadzicki D . Diagnostic accuracy of methods for the detection of BRCA1 and BRCA2 mutations: a systematic review. Eur J Hum Genet. 2007; 15(6):619-27. DOI: 10.1038/sj.ejhg.5201806. View

Ford D, Easton D, Bishop D, Narod S, Goldgar D . Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet. 1994; 343(8899):692-5. DOI: 10.1016/s0140-6736(94)91578-4. View

Ponder B, Antoniou A, Dunning A, Easton D, Pharoah P . Polygenic inherited predisposition to breast cancer. Cold Spring Harb Symp Quant Biol. 2006; 70:35-41. DOI: 10.1101/sqb.2005.70.029. View

Somasundaram K . Breast cancer gene 1 (BRCA1): role in cell cycle regulation and DNA repair--perhaps through transcription. J Cell Biochem. 2003; 88(6):1084-91. DOI: 10.1002/jcb.10469. View

Peto J, Collins N, Barfoot R, Seal S, Warren W, Rahman N . Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. J Natl Cancer Inst. 1999; 91(11):943-9. DOI: 10.1093/jnci/91.11.943. View

Mann G, Thorne H, Balleine R, Butow P, Clarke C, Edkins E . Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource. Breast Cancer Res. 2006; 8(1):R12. PMC: 1413975. DOI: 10.1186/bcr1377. View

Balmana J, Diez O, Castiglione M . BRCA in breast cancer: ESMO clinical recommendations. Ann Oncol. 2009; 20 Suppl 4:19-20. DOI: 10.1093/annonc/mdp116. View

Easton D . How many more breast cancer predisposition genes are there?. Breast Cancer Res. 2001; 1(1):14-7. PMC: 138504. DOI: 10.1186/bcr6. View

Kumar B, Lakhotia S, Ankathil R, Madhavan J, Jayaprakash P, Nair M . Germline BRCA1 mutation analysis in Indian breast/ovarian cancer families. Cancer Biol Ther. 2002; 1(1):18-21. DOI: 10.4161/cbt.1.1.33. View

10.

McKean-Cowdin R, Feigelson H, Xia L, Pearce C, Thomas D, Stram D . BRCA1 variants in a family study of African-American and Latina women. Hum Genet. 2005; 116(6):497-506. DOI: 10.1007/s00439-004-1240-5. View

11.

Vaidyanathan K, Lakhotia S, Ravishankar H, Tabassum U, Mukherjee G, Somasundaram K . BRCA1 and BRCA2 germline mutation analysis among Indian women from south India: identification of four novel mutations and high-frequency occurrence of 185delAG mutation. J Biosci. 2009; 34(3):415-22. DOI: 10.1007/s12038-009-0048-9. View

12.

Rajkumar T, Soumittra N, Nancy N, Swaminathan R, Sridevi V, Shanta V . BRCA1, BRCA2 and CHEK2 (1100 del C) germline mutations in hereditary breast and ovarian cancer families in South India. Asian Pac J Cancer Prev. 2003; 4(3):203-8. View

13.

Lakhotia S, Somasundaram K . Conformation-sensitive gel electrophoresis for detecting BRCA1 mutations. Methods Mol Biol. 2003; 223:403-12. DOI: 10.1385/1-59259-329-1:403. View

14.

Valarmathi M, Sawhney M, Deo S, Shukla N, Das S . Novel germline mutations in the BRCA1 and BRCA2 genes in Indian breast and breast-ovarian cancer families. Hum Mutat. 2004; 23(2):205. DOI: 10.1002/humu.9213. View

15.

Hedau S, Jain N, Husain S, Mandal A, Ray G, Shahid M . Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India. Breast Cancer Res Treat. 2004; 88(2):177-86. DOI: 10.1007/s10549-004-0593-8. View

16.

Miki Y, Swensen J, Futreal P, Harshman K, Tavtigian S, Liu Q . A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994; 266(5182):66-71. DOI: 10.1126/science.7545954. View

17.

Saxena S, Szabo C, Chopin S, Barjhoux L, Sinilnikova O, Lenoir G . BRCA1 and BRCA2 in Indian breast cancer patients. Hum Mutat. 2002; 20(6):473-4. DOI: 10.1002/humu.9082. View

18.

Saxena S, Chakraborty A, Kaushal M, Kotwal S, Bhatanager D, Mohil R . Contribution of germline BRCA1 and BRCA2 sequence alterations to breast cancer in Northern India. BMC Med Genet. 2006; 7:75. PMC: 1617095. DOI: 10.1186/1471-2350-7-75. View

19.

Wooster R, Neuhausen S, Mangion J, Quirk Y, Ford D, Collins N . Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science. 1994; 265(5181):2088-90. DOI: 10.1126/science.8091231. View

20.

Narod S, Foulkes W . BRCA1 and BRCA2: 1994 and beyond. Nat Rev Cancer. 2004; 4(9):665-76. DOI: 10.1038/nrc1431. View